Jubilant Therapeutics Inc.

Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which integrates structure-based design and computational algorithms to discover and develop novel, precision therapeutics against both first-in-class and validated but intractable targets in genetically-defined patient populations. Striving for speed and efficiency by employing a business model that leverages the proven and synergistic capabilities of Jubilant Pharmova Limited`s value chain and shared services. Guided by globally renowned key opinion leaders and scientific advisory board members.